NEW YORK , Feb. 25, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Novo Nordisk A/S ("Novo" or the "Company") (NASDAQ: NVO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

NEW YORK , Feb. 25, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Construction Partners, Inc. ("Construction Partners" or the "Company") (NYSE: ROAD). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , Feb. 25, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against ModivCare, Inc. ("ModivCare" or the "Company") (NASDAQ: MODV). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

Goldman Sachs analyst Kash Rangan maintained a Buy rating and price forecast for MongoDB, Inc. MDB following the company's acquisition of Voyage AI on Monday.

Claritev Corporation (MPLN) Q4 2024 Earnings Call Transcript

NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, “we,” “us,” “our,” “CGBD” or the “Company”) (NASDAQ: CGBD) today announced its financial results for its fourth quarter and full year ended December 31, 2024. Justin Plouffe, CGBD's Chief Executive Officer said, “CGBD produced a strong finish to 2024 with portfolio growth driven by fourth quarter net investment activity. Net investment income remained comfortably above our base dividend and consistent with the prior quarter, despite tightening market spreads and continued repricing activity. We are very pleased with our performance throughout the fourth quarter …

Remote-First-Company // HALF MOON BAY, Calif.--(BUSINESS WIRE)--Coinbase Global, Inc. announced today that Brian Armstrong, Co-Founder and CEO, and Alesia Haas, Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley Technology, Media, and Telecom Conference on Tuesday, March 4, 2024 at 4:05 pm ET / 1:05 pm PT. A live webcast and replay of the virtual session will be available on Coinbase's Investor Relations website at https://investor.coinbase.com. Disclosure Inform.

DENVER--(BUSINESS WIRE)--Ibotta (NYSE: IBTA), which operates the largest digital promotions network in North America, announced today that CEO and founder, Bryan Leach, will participate in a fireside chat at The Citizens JMP Technology Conference in San Francisco on Tues., March 4 at 9:30 am PT. Audio webcasts of the event will be available on the investor relations section of the Ibotta website at investors.ibotta.com.

LOS ANGELES , Feb. 25, 2025 /PRNewswire/ -- Revolve Group, Inc. (NYSE: RVLV), the next-generation fashion retailer for Millennial and Generation Z consumers, today announced financial results for the fourth quarter and full year ended December 31, 2024. "We finished the year with an outstanding fourth quarter, highlighted by double-digit top-line growth year-over-year and a more than doubling of net income and Adjusted EBITDA year-over-year," said co-founder and co-CEO Mike Karanikolas.

SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported financial results for the fourth quarter and year ended December 31, 2024.

For the past two years, artificial intelligence has fueled an extraordinary bull run in the stock market, with large language models and AI-powered applications transforming the world. No company has benefited more from this revolution than Nvidia ( NVDA ).

MELI's Q4 strength impresses, but premium valuation gives pause. Investors can hold the stock or find better entry points in 2025 as competition intensifies.

POWL is making strides in the electrical equipment market, which makes the stock worth a watch amid certain challenges.

Weak shipping revenues are likely to have dented INSW's fourth-quarter top-line performance.

ARCC's attractive dividend yield of 8.25% is impressive. Is the stock worth betting on to earn this dividend yield?

Fiscal Fourth Quarter Total Revenues of $2.211 Billion, Up 15.0% Year Over Year Subscription Revenues of $2.040 Billion, Up 15.9% Year Over Year Fiscal Year 2025 Total Revenues of $8.446 Billion, Up 16.4% Year Over Year Subscription Revenues of $7.718 Billion, Up 16.9% Year Over Year Operating Cash Flows of $2.461 Billion, Up 14.5% Year Over Year PLEASANTON, Calif. , Feb. 25, 2025 /PRNewswire/ -- Workday, Inc. (NASDAQ: WDAY), the AI platform for managing people and money , today announced results for the fiscal 2025 fourth quarter and full year ended January 31, 2025.

SCOTTSDALE, Ariz. , Feb. 25, 2025 /PRNewswire/ -- Axon Cloud & Services revenue grows 44% to $806 million Annual recurring revenue grows 37% to $1.0 billion Annual net income of $377 million supports non-GAAP net income of $466 million Company establishes fiscal year 2025 revenue guidance of $2.55 billion to $2.65 billion, representing approximately 25% annual growth at the midpoint Fellow shareholders, Axon is proud to report the closing of an evolutionary year defined by innovative product leadership, deep customer collaboration and unwavering commitment to our mission of protecting life.

BOULDER, CO / ACCESS Newswire / February 25, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, today announced that it will be exhibiting at the 2025 American Academy of Dermatology (AAD) Annual Meeting in Orlando, Florida, March 7-11, 2025. The AAD annual meeting is one of the leading dermatology conferences in the U.S., with over 350 exhibitors and close to 20,000 attendees, including more than …

SAN DIEGO , Feb. 25, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at two upcoming investor conferences in March. Chief Executive Officer Kyle Gano, Chief Financial Officer Matt Abernethy, and Chief Commercial Officer Eric Benevich will present at the TD Cowen 45th Annual Health Care Conference on Tuesday, March 4, 2025 at 11:10 AM Eastern Time in Boston.

2024 Fourth Quarter Revenue of $481.4 Million, up 16.3% year-over-year Q4 Diluted EPS (GAAP) of $0.31, up 28.4% from $0.24 in Q4 of 2023 Q4 Adjusted Diluted EPS (Non-GAAP) (1) of $0.44, up 26.1% from $0.35 in Q4 of 2023